A carregar...
Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions
BACKGROUND AND PURPOSE: Telmisartan suppresses the development of endometriotic lesions. However, the drug also up‐regulates the expression of COX‐2, which has been suggested to promote the progression of endometriosis. Accordingly, in the present study we analysed whether a combination therapy with...
Na minha lista:
| Publicado no: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5522992/ https://ncbi.nlm.nih.gov/pubmed/28548231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13874 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|